ArticleDiscover oncology2025

Development and validation of a hypoxia-immune-based microenvironment gene signature for predicting survival in non-small cell lung cancer.

Xiangwu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.